US FDA Approves Bayer's AMBELVIST for Contrast-Enhanced MRI
Bayer’s AMBELVIST (gadoquatrane) has received US FDA approval for contrast-enhanced MRI to detect and visualise lesions with abnormal vascularity in the Central Nervous System (CNS) and other body regions. The approval expands advanced imaging options with a next-generation gadolinium-based contrast agent for improved diagnostic evaluation.
Magnetic Resonance Imaging (MRI) | 15/06/2026 | By News Bureau | 115
Cook Medical, Siemens Healthineers Partner to Develop Radiation-Free iMRI Suite
Cook Medical and Siemens Healthineers have announced a strategic commercial partnership to develop the Interventional MRI (iMRI) Suite, a first-of-its-kind, radiation-free solution designed to transform minimally invasive procedures.
Magnetic Resonance Imaging (MRI) | 13/09/2025 | By Dineshwori | 220
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy